Cargando…

Impacto del SARS-CoV-2 en el diagnóstico de bacteriemia comunitaria en un hospital terciario

OBJECTIVE: We carry out an analysis of the bacteremia diagnosed in the Emergency Department during 2020, coinciding with the period of the pandemic. METHOD: We performed a retrospective analysis from March 4, 2020 to December 31, 2020. RESULTS: The number of patients who went to the Emergency Depart...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayo, Saray Mormeneo, Hijazo, Miguel Moreno, Ruíz, María Pilar Palacián, Usón, María Cruz Villuendas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790650/
https://www.ncbi.nlm.nih.gov/pubmed/34983173
http://dx.doi.org/10.37201/req/104.2021
_version_ 1784640063700729856
author Bayo, Saray Mormeneo
Hijazo, Miguel Moreno
Ruíz, María Pilar Palacián
Usón, María Cruz Villuendas
author_facet Bayo, Saray Mormeneo
Hijazo, Miguel Moreno
Ruíz, María Pilar Palacián
Usón, María Cruz Villuendas
author_sort Bayo, Saray Mormeneo
collection PubMed
description OBJECTIVE: We carry out an analysis of the bacteremia diagnosed in the Emergency Department during 2020, coinciding with the period of the pandemic. METHOD: We performed a retrospective analysis from March 4, 2020 to December 31, 2020. RESULTS: The number of patients who went to the Emergency Department during the study period and the number of extracted blood cultures decreased by 46.79% and 35.7% compared to the same period in 2019 (p <0.05). 320 bacteremia occurred while 507 occurred in 2019, assuming a decrease of 36.8% (p <0.05). The positivity rate of blood cultures was 7.09% in 2020 and 7.23% in 2019 and the contamination rate was 7.07 % in 2020 and 5.67% in 2019. The most frequently isolated microorganism was Escherichia coli, followed by Staphylococcus aureus and Klebsiella pneumoniae. A 6.62% of the isolated E. coli were carriers of extended-spectrum beta-lactamases (ESBL). The percentage of methicillin-resistant S. aureus was 12.9 % and that of K. pneumoniae ESBL was 11.54%. CONCLUSION: During the SARS-CoV-2 pandemic there has been a decrease in the number of bacteremia diagnoses, it is possible that attention was focused especially on COVID, forgetting other diseases, such as bacteremia.
format Online
Article
Text
id pubmed-8790650
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedad Española de Quimioterapia
record_format MEDLINE/PubMed
spelling pubmed-87906502022-02-07 Impacto del SARS-CoV-2 en el diagnóstico de bacteriemia comunitaria en un hospital terciario Bayo, Saray Mormeneo Hijazo, Miguel Moreno Ruíz, María Pilar Palacián Usón, María Cruz Villuendas Rev Esp Quimioter Brief Report OBJECTIVE: We carry out an analysis of the bacteremia diagnosed in the Emergency Department during 2020, coinciding with the period of the pandemic. METHOD: We performed a retrospective analysis from March 4, 2020 to December 31, 2020. RESULTS: The number of patients who went to the Emergency Department during the study period and the number of extracted blood cultures decreased by 46.79% and 35.7% compared to the same period in 2019 (p <0.05). 320 bacteremia occurred while 507 occurred in 2019, assuming a decrease of 36.8% (p <0.05). The positivity rate of blood cultures was 7.09% in 2020 and 7.23% in 2019 and the contamination rate was 7.07 % in 2020 and 5.67% in 2019. The most frequently isolated microorganism was Escherichia coli, followed by Staphylococcus aureus and Klebsiella pneumoniae. A 6.62% of the isolated E. coli were carriers of extended-spectrum beta-lactamases (ESBL). The percentage of methicillin-resistant S. aureus was 12.9 % and that of K. pneumoniae ESBL was 11.54%. CONCLUSION: During the SARS-CoV-2 pandemic there has been a decrease in the number of bacteremia diagnoses, it is possible that attention was focused especially on COVID, forgetting other diseases, such as bacteremia. Sociedad Española de Quimioterapia 2022-01-05 2022 /pmc/articles/PMC8790650/ /pubmed/34983173 http://dx.doi.org/10.37201/req/104.2021 Text en © The Author 2021 https://creativecommons.org/licenses/by-nc/4.0/Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Brief Report
Bayo, Saray Mormeneo
Hijazo, Miguel Moreno
Ruíz, María Pilar Palacián
Usón, María Cruz Villuendas
Impacto del SARS-CoV-2 en el diagnóstico de bacteriemia comunitaria en un hospital terciario
title Impacto del SARS-CoV-2 en el diagnóstico de bacteriemia comunitaria en un hospital terciario
title_full Impacto del SARS-CoV-2 en el diagnóstico de bacteriemia comunitaria en un hospital terciario
title_fullStr Impacto del SARS-CoV-2 en el diagnóstico de bacteriemia comunitaria en un hospital terciario
title_full_unstemmed Impacto del SARS-CoV-2 en el diagnóstico de bacteriemia comunitaria en un hospital terciario
title_short Impacto del SARS-CoV-2 en el diagnóstico de bacteriemia comunitaria en un hospital terciario
title_sort impacto del sars-cov-2 en el diagnóstico de bacteriemia comunitaria en un hospital terciario
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790650/
https://www.ncbi.nlm.nih.gov/pubmed/34983173
http://dx.doi.org/10.37201/req/104.2021
work_keys_str_mv AT bayosaraymormeneo impactodelsarscov2eneldiagnosticodebacteriemiacomunitariaenunhospitalterciario
AT hijazomiguelmoreno impactodelsarscov2eneldiagnosticodebacteriemiacomunitariaenunhospitalterciario
AT ruizmariapilarpalacian impactodelsarscov2eneldiagnosticodebacteriemiacomunitariaenunhospitalterciario
AT usonmariacruzvilluendas impactodelsarscov2eneldiagnosticodebacteriemiacomunitariaenunhospitalterciario